Group items tagged

A research team led by the University of Strathclyde in the UK has developed an artificial intelligence (AI)-based blood test for the diagnosis of brain cancer.

Patients with advanced non-small cell lung cancer (NSCLC) may soon be offered a blood test to assess their treatment options, instead of having to provide a tumour sample for analysis.

Immuno-Transcriptomics firm Novigenix has received positive results from its early colon cancer detection blood test at the European Society for Medical Oncology (ESMO) 2019.

Cancer Research UK has announced a £56m research network to transform the UK into a global hub for radiotherapy study. By leveraging the use of the latest techniques, such as FLASH radiotherapy and artificial intelligence (AI), the network aims to accelerate the development of advanced radiotherapy.

Researchers from the Abramson Cancer Center of the University of Pennsylvania have found that liquid biopsy can help to predict the prognosis of glioblastoma(GBM), the most aggressive and common brain cancer in adults.

Qiagen has launched the new therascreen PIK3CA RGQ PCR Kit as a companion diagnostic for the detection of patients who could benefit from treatment with Swiss pharmaceutical company Novartis' new breast cancer drug, Piqray (alpelisib).

Cancer/Tumor Profiling Market

The latest report published by Reports & Insights highlighted the development and the growth of the global Biologics Market, which further includes the detailed information about the market potential and profound knowledge of the trends prevailing in the market. The global Biologics Market is projected to rise steadily over the anticipated future as per the report estimates. The research study named "Biologics Market: Opportunity Analysis and Future Assessment 2020-2028", is aimed to provide a quantitative and qualitative outline of the conceptual structure and analytical approach of the market elaborated using attested research methodologies and proficient expertise. The biologics market is estimated to reach at a value of US 339.3 Bn by the end of 2022 and expected to reach at a value of US$ 610.2 Bn by 2030 with a significant CAGR of 7.6%. Request a Sample Copy of this Report @: https://reportsandinsights.com/sample-request/2349 Biologics Introduction Biologics, or a biologic drug, is a substance that is made from living creatures or comprise elements of living creatures. Biologic drugs consist of an extensive range of by-products obtained from microorganisms, animals, and humans by the usage of biotechnology. The various kinds of biologic drugs or biologics comprises blood and its components, cells, vaccines, genes, allergens, tissues, and recombinant proteins. Biologics Market Dynamics A biologic is created in a life system including animal or plant cells, or microorganisms that are majorly used to impede, diagnose, and to treat, or cure a wide range of illnesses such as chronic kidney disease, cancer, infectious diseases, and autoimmune disorders. In the present times, the rising incidence of chronic diseases such as autoimmune diseases, diabetes, and cancer among the population owing to the lethargic lifestyle, poor diet, and desk-bound jobs is mainly encouraging the demand of biologics in the global market, thus propelling the growth of the

Reports and Insights freshly added a report titled "Pharma Drug Delivery Market: Opportunity Analysis and Future Assessment 2022-2030" in its database of market research reports which offers its readers a detailed and profound analysis on the fresh growth opportunities, trends and growth drivers that are closely linked with the growth of the market. The report further provides crucial insights on the COVID-19 impacts on the Pharma Drug Delivery Market along with the compound growth rate (CAGR) of the market for a forecasted period between 2022 and 2030. The report also comprises assessment of the market by employing various analytical tools, such as Porter's five forces analysis and PESTEL analysis. These tools also offer an in-depth analysis on the micro and macro-environmental factors that are related to the growth of the market over the projected period.  The global pharma drug delivery market is estimated to reach at a value of US$ 1,422.8 Bn by the end of 2020 and expected to reach at a value of US$ 2,418.4 Bn by 2028 with a significant CAGR of 6.9% Request a Sample Copy of this Report @: https://reportsandinsights.com/sample-request/1393 Pharma Drug Delivery Introduction A pharmaceutical drug delivery (DDS) is a fabrication or an equipment, which is used for the infusion of a therapeutic matter into the human body. This system operates by administering medications to precisely targeted parts of the body by the help of a means, which can regulate the administration of the therapy by the medium of each of two chemical or physiological prompts. The drug delivery system is mainly employed to enhance the efficiency and safety of an infused drug by regulating the time, degree, and part of dispensation of drug in the body. Moreover, drug delivery systems are also bifurcated into further two types including conventional drug delivery system and novel drug delivery system. Conventional drug delivery system involves the most general techniques of drug deliver

Reports and Insights freshly added a report titled "Chronic Ocular Graft-Versus-Host Disease Market: Opportunity Analysis and Future Assessment 2023-2030" in its database of market research reports which offers its readers a detailed and profound analysis on the fresh growth opportunities, trends and growth drivers that are closely linked with the growth of the market. The report further provides crucial insights on the COVID-19 impacts on the Chronic Ocular Graft-Versus-Host Disease Market along with the compound growth rate (CAGR) of the market for a forecasted period between 2023 and 2030. The report also comprises assessment of the market by employing various analytical tools, such as Porter's five forces analysis and PESTEL analysis. These tools also offer an in-depth analysis on the micro and macro-environmental factors that are related to the growth of the market over the projected period.  The global chronic ocular graft-versus-host disease market in 2020 is accounted for more than US$ xx Bn and expected to reach a value of US$ xx Bn by 2028 with a significant CAGR of 4.2%. Chronic Ocular Graft-Versus-Host Disease Market: https://reportsandinsights.com/sample-request/1225 Chronic Ocular Graft-Versus-Host Disease Market Dynamics The rising prevalence of bone marrow cancers and the increasing number of road accidents among individuals across the globe are the major factors driving the growth of the global chronic ocular graft-versus-host disease market. For instance, according to data published by World Health Organization (WHO), in September 2018, Cancer is the second leading cause of death globally and is responsible for an estimated 9.6 Mn deaths in 2018. Moreover, growing research and development activities on diagnosis management, coupled with a huge new pipeline of drugs are further propelling the growth of the global chronic ocular graft-versus-host disease market. However, factors such as low societal awareness, delayed diagnosis, and low go

A new study in The Prostate suggests that eating deep fried foods, high heat cooking, and fast food increase the risk of prostate cancer (PCa).

Litchi is a fruit with amazing health benefits belongs to Sapindaceae family. It is grown in the tropical and subtropical regions of the world and found abundantly in the summer season. It was first originated in the Chinese regions of Guangdong and Fujian and has been started cultivating in the various countries of the world (India, Vietnam, Sri Lanka, Thailand, Taiwan, Japan, Bangladesh, Nepal, Australia, Pakistan, Malaysia, Vietnam, Mexico, Southern Africa and etc). It is very delicate and attractive smelling fruit which is usually eaten fresh. It is found in many types such as emperor lychee or biggest lychee, ohia lychee or litchi with little seed, Brewster lychee and etc. Benefits of Litchi (Lychee) Fruit Juice It is loaded with numerous healthy nutrients including vitamins, minerals, antioxidants, fatty acids and so many. It protects from various diseases, infections and skin problems by enhancing the immunity power. It contains polyphenols which helps in fighting with weight problems, liver damage and type-2 diabetes. Some of its amazing health benefits are mentioned below: Benefits of Litchi for Heart Benefits of Litchi for Cancer Benefits of Litchi for Digestive System Benefits of Litchi for Bones, Teeth and Joints Benefits of Litchi for Hair Benefits of Litchi for Weight Loss Benefits of Litchi for Aging Benefits of Litchi for Women during Pregnancy Benefits of Litchi for Kids Benefits of Litchi for Men Benefits of Litchi Seeds Benefits of Litchi Juice of Skin Nutrition Facts of Litchi Dash per 100 ml Energy: 60 Kcal Fat: 0 gm Carbohydrate: 14.8 gm Protein: 0 gm Sugar: 12.5 g Vitamins Thiamine: 0.011 mg Riboflavin: 0.065 mg Niacin: 0.603 mg Choline: 7.1 mg Pyridoxine: 0.100 mg Folates: 14 µg Vitamin C: 71.5 mg Vitamin E: 0.07 mg Vitamin K: 0.4 µg Minerals Calcium: 5 mg Copper: 0.148 mg Iron: 0.31 mg Magnesium: 10 mg Manganese: 0.055 mg Phosphorus: 31 mg Selenium: 0.6 µg Zinc: 0.07 mg

Have you checked this for Business in Healthcare

Unforgettable Nat King Cole died from lung cancer in 1965 In December, he was working in San Francisco when he was finally persuaded by friends to seek medical help. A malignant tumor in an advanced state of growth on his left lung was observed on a chest X-ray... #news #singer #trendbuddies #working #finallypersuaded #maliganttumor #advanced #natkingcole https://trendbuddies.com/unforgettable-nat-king-cole-died/

Novartis has said that Kisqali delivered superior overall survival (OS) in the Monaleesa-3 trial, demonstrating more life for postmenopausal human epidermal growth factor receptor-2 negative (HR+/HER2-) advanced breast cancer patients.

ImmunoGen has presented full data from the Phase III Forward I study of mirvetuximab soravtansine in ovarian cancer at the European Society for Medical Oncology (ESMO) 2019 Congress in Barcelona, Spain, saying that it failed to meet the primary endpoint of progression-free survival (PFS).

Advances in cancer treatments, such as immunotherapies and precision medicines, have been associated with a corresponding rise in the cost of new and innovative medicines.

The report is titled as 'Oncology Small Molecule Drugs Market: Opportunity Analysis and Future Assessment 2022-2030'. An overview of conceptual frameworks, analytical approaches of the Oncology Small Molecule Drugs market is the main objective of the report, which further consists the market opportunity and insights of the data involved in the making of the respective market.